
No clinical or biological parameter can predict oocyte quality. In women with uncertain ovarian function, antral follicle count and serum anti-Müllerian hormone/Müllerian-inhibiting substance appear to be more discriminatory markers of ovarian reserve and assisted reproductive technology outcome. FSH levels should be correlated with estradiol levels, antral follicle count, and patient age.
Anti-Mullerian Hormone, Estradiol, Ovary, Testicular Hormones, Ovarian Follicle, Oocytes, Humans, Female, Follicle Stimulating Hormone, Glycoproteins, Ultrasonography
Anti-Mullerian Hormone, Estradiol, Ovary, Testicular Hormones, Ovarian Follicle, Oocytes, Humans, Female, Follicle Stimulating Hormone, Glycoproteins, Ultrasonography
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
